The peptide problem: Hype is outrunning the evidence Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance Sports Medicine Springer Nature Link FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York